Piedmont Dialysis Center Of Wake Forest University in Winston Salem, North Carolina - Dialysis Center

Piedmont Dialysis Center Of Wake Forest University is a medicare approved dialysis facility center in Winston Salem, North Carolina and it has 58 dialysis stations. It is located in Forsyth county at 655 Cotton Street, Winston Salem, NC, 27101. You can reach out to the office of Piedmont Dialysis Center Of Wake Forest University at (336) 721-1360. This dialysis clinic is managed and/or owned by Wake Forest University. Piedmont Dialysis Center Of Wake Forest University has the following ownership type - Non-Profit. It was first certified by medicare in September, 1976. The medicare id for this facility is 342505 and it accepts patients under medicare ESRD program.

Dialysis Center Profile

NamePiedmont Dialysis Center Of Wake Forest University
Location655 Cotton Street, Winston Salem, North Carolina
No. of Dialysis Stations 58
Medicare ID342505
Managed ByWake Forest University
Ownership TypeNon-Profit
Late Shifts No

Contact Information


655 Cotton Street, Winston Salem, North Carolina, 27101
(336) 721-1360

News Archive

COVID-19 patients at high risk for developing complications associated with blood clots

When researchers from the University of Colorado Anschutz Medical Campus, Aurora, used a combination of two specific blood-clotting tests, they found critically ill patients infected with Coronavirus Disease 2019 (COVID-19) who were at high risk for developing renal failure, venous blood clots, and other complications associated with blood clots, such as stroke.

ScinoPharm to be Clinical Data's sole API supplier of vilazodone hydrochloride during Viibryd's launch

ScinoPharm, a leading active pharmaceutical ingredient (API) and contract research and manufacturing (CRAM) service provider to the global pharmaceutical and biotechnology industry, will provide commercial manufacturing service of vilazodone hydrochloride active pharmaceutical ingredient (API) for Clinical Data, Inc.'s Viibryd™, a new drug entity recently approved by the United States Food and Drug Administration.

Bath scientists receive funding to monitor wastewater in cities in the UK and Africa

Chemists, biologists and mathematicians from the University of Bath have received funding to monitor wastewater in cities in the UK and Africa, to provide an early warning of the potential spread of COVID-19.

Adding protein sarcospan to muscle cells might help Duchenne muscular dystrophy

The overlooked and undervalued protein, sarcospan, just got its moment in the spotlight.

Read more Medical News

› Verified 5 days ago


Map and Direction



NPI Associated with this Dialysis Facility:

Dialysis Facilities may have multiple NPI numbers. We have found possible NPI number/s associated with Piedmont Dialysis Center Of Wake Forest University from NPPES records by matching pattern on the basis of name, address, phone number etc. Please use this information accordingly.

NPI Number1801873831
Organization NamePiedmont Dialysis Center
Doing Business AsPiedmont Dialysis Center Of Wake Forest University
Address655 Cotton St Winston-salem, North Carolina, 27101
Phone Number(336) 721-1360

News Archive

COVID-19 patients at high risk for developing complications associated with blood clots

When researchers from the University of Colorado Anschutz Medical Campus, Aurora, used a combination of two specific blood-clotting tests, they found critically ill patients infected with Coronavirus Disease 2019 (COVID-19) who were at high risk for developing renal failure, venous blood clots, and other complications associated with blood clots, such as stroke.

ScinoPharm to be Clinical Data's sole API supplier of vilazodone hydrochloride during Viibryd's launch

ScinoPharm, a leading active pharmaceutical ingredient (API) and contract research and manufacturing (CRAM) service provider to the global pharmaceutical and biotechnology industry, will provide commercial manufacturing service of vilazodone hydrochloride active pharmaceutical ingredient (API) for Clinical Data, Inc.'s Viibryd™, a new drug entity recently approved by the United States Food and Drug Administration.

Bath scientists receive funding to monitor wastewater in cities in the UK and Africa

Chemists, biologists and mathematicians from the University of Bath have received funding to monitor wastewater in cities in the UK and Africa, to provide an early warning of the potential spread of COVID-19.

Adding protein sarcospan to muscle cells might help Duchenne muscular dystrophy

The overlooked and undervalued protein, sarcospan, just got its moment in the spotlight.

Read more Medical News

› Verified 5 days ago


Survey of Patient's Experiences

Nephrologists Performance Ratings

Experience MeasureProviderNational Avg.
Patients who reported that nephrologists always communicated and cared for them.62%67%
Patients who reported that nephrologists usually communicated and cared for them.16%15%
Patients who reported that nephrologists sometimes or never communicated and cared for them.22%18%
Patients who gave their nephrologists a rating of 9 or 10 on a scale of 0 (worst possible) to 10 (best possible).55%60%
Patients who gave their nephrologists a rating of 7 or 8 on a scale of 0 (worst possible) to 10 (best possible).31%26%
Patients who gave their nephrologists a rating of 6 or less than 6 on a scale of 0 (worst possible) to 10 (best possible).14%14%

News Archive

COVID-19 patients at high risk for developing complications associated with blood clots

When researchers from the University of Colorado Anschutz Medical Campus, Aurora, used a combination of two specific blood-clotting tests, they found critically ill patients infected with Coronavirus Disease 2019 (COVID-19) who were at high risk for developing renal failure, venous blood clots, and other complications associated with blood clots, such as stroke.

ScinoPharm to be Clinical Data's sole API supplier of vilazodone hydrochloride during Viibryd's launch

ScinoPharm, a leading active pharmaceutical ingredient (API) and contract research and manufacturing (CRAM) service provider to the global pharmaceutical and biotechnology industry, will provide commercial manufacturing service of vilazodone hydrochloride active pharmaceutical ingredient (API) for Clinical Data, Inc.'s Viibryd™, a new drug entity recently approved by the United States Food and Drug Administration.

Bath scientists receive funding to monitor wastewater in cities in the UK and Africa

Chemists, biologists and mathematicians from the University of Bath have received funding to monitor wastewater in cities in the UK and Africa, to provide an early warning of the potential spread of COVID-19.

Adding protein sarcospan to muscle cells might help Duchenne muscular dystrophy

The overlooked and undervalued protein, sarcospan, just got its moment in the spotlight.

Read more Medical News

› Verified 5 days ago

Dialysis Center Staff Performance Ratings

Experience MeasureProviderNational Avg.
Patients who reported that dialysis center staff always communicated well, kept patients comfortable and pain-free as possible.49%62%
Patients who reported that dialysis center staff usually communicated, kept patients comfortable and pain-free as possible.24%20%
Patients who reported that dialysis center staff sometimes or never communicated, kept patients comfortable and pain-free.27%18%
Patients who gave their dialysis facility staff a rating of 9 or 10 on a scale of 0 (worst possible) to 10 (best possible).42%62%
Patients who gave their dialysis facility staff a rating of 7 or 8 on a scale of 0 (worst possible) to 10 (best possible).38%26%
Patients who gave their dialysis facility staff a rating of 6 or less than 6 on a scale of 0 (worst possible) to 10 (best possible).20%12%

News Archive

COVID-19 patients at high risk for developing complications associated with blood clots

When researchers from the University of Colorado Anschutz Medical Campus, Aurora, used a combination of two specific blood-clotting tests, they found critically ill patients infected with Coronavirus Disease 2019 (COVID-19) who were at high risk for developing renal failure, venous blood clots, and other complications associated with blood clots, such as stroke.

ScinoPharm to be Clinical Data's sole API supplier of vilazodone hydrochloride during Viibryd's launch

ScinoPharm, a leading active pharmaceutical ingredient (API) and contract research and manufacturing (CRAM) service provider to the global pharmaceutical and biotechnology industry, will provide commercial manufacturing service of vilazodone hydrochloride active pharmaceutical ingredient (API) for Clinical Data, Inc.'s Viibryd™, a new drug entity recently approved by the United States Food and Drug Administration.

Bath scientists receive funding to monitor wastewater in cities in the UK and Africa

Chemists, biologists and mathematicians from the University of Bath have received funding to monitor wastewater in cities in the UK and Africa, to provide an early warning of the potential spread of COVID-19.

Adding protein sarcospan to muscle cells might help Duchenne muscular dystrophy

The overlooked and undervalued protein, sarcospan, just got its moment in the spotlight.

Read more Medical News

› Verified 5 days ago

Overall Dialysis Center Performance Ratings

Experience MeasureProviderNational Avg.
Patients who reported that 'YES', their nephrologists and dialysis center staff provided them the information they needed to take care of them. 77%80%
Patients who reported that 'NO', their nephrologists and dialysis center staff does not provided them the information they needed to take care of them.23%20%
Patients who gave their dialysis center a rating of 9 or 10 on a scale of 0 (worst possible) to 10 (best possible).44%68%
Patients who gave their dialysis center a rating of 7 or 8 on a scale of 0 (worst possible) to 10 (best possible).38%20%
Patients who gave their dialysis center a rating of 6 or less than 6 on a scale of 0 (worst possible) to 10 (best possible).18%12%

News Archive

COVID-19 patients at high risk for developing complications associated with blood clots

When researchers from the University of Colorado Anschutz Medical Campus, Aurora, used a combination of two specific blood-clotting tests, they found critically ill patients infected with Coronavirus Disease 2019 (COVID-19) who were at high risk for developing renal failure, venous blood clots, and other complications associated with blood clots, such as stroke.

ScinoPharm to be Clinical Data's sole API supplier of vilazodone hydrochloride during Viibryd's launch

ScinoPharm, a leading active pharmaceutical ingredient (API) and contract research and manufacturing (CRAM) service provider to the global pharmaceutical and biotechnology industry, will provide commercial manufacturing service of vilazodone hydrochloride active pharmaceutical ingredient (API) for Clinical Data, Inc.'s Viibryd™, a new drug entity recently approved by the United States Food and Drug Administration.

Bath scientists receive funding to monitor wastewater in cities in the UK and Africa

Chemists, biologists and mathematicians from the University of Bath have received funding to monitor wastewater in cities in the UK and Africa, to provide an early warning of the potential spread of COVID-19.

Adding protein sarcospan to muscle cells might help Duchenne muscular dystrophy

The overlooked and undervalued protein, sarcospan, just got its moment in the spotlight.

Read more Medical News

› Verified 5 days ago

Patient Distribution

Anemia Management

Dialysis patients with Hemoglobin data152
Medicare patients who had average hemoglobin (hgb) less than 10 g/dL20

News Archive

COVID-19 patients at high risk for developing complications associated with blood clots

When researchers from the University of Colorado Anschutz Medical Campus, Aurora, used a combination of two specific blood-clotting tests, they found critically ill patients infected with Coronavirus Disease 2019 (COVID-19) who were at high risk for developing renal failure, venous blood clots, and other complications associated with blood clots, such as stroke.

ScinoPharm to be Clinical Data's sole API supplier of vilazodone hydrochloride during Viibryd's launch

ScinoPharm, a leading active pharmaceutical ingredient (API) and contract research and manufacturing (CRAM) service provider to the global pharmaceutical and biotechnology industry, will provide commercial manufacturing service of vilazodone hydrochloride active pharmaceutical ingredient (API) for Clinical Data, Inc.'s Viibryd™, a new drug entity recently approved by the United States Food and Drug Administration.

Bath scientists receive funding to monitor wastewater in cities in the UK and Africa

Chemists, biologists and mathematicians from the University of Bath have received funding to monitor wastewater in cities in the UK and Africa, to provide an early warning of the potential spread of COVID-19.

Adding protein sarcospan to muscle cells might help Duchenne muscular dystrophy

The overlooked and undervalued protein, sarcospan, just got its moment in the spotlight.

Read more Medical News

› Verified 5 days ago

Dialysis Adequacy

Adult patinets who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be atleast 1.7, that means they are receiving right amount of dialysis. Pediatric patients who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be 1.8.
Higher percentages should be better.

  • Hemodialysis
    Adult patients getting regular hemodialysis at the center184
    Adult patient months included in Kt/V greater than or equal to 1.21573
    Percentage of adult patients getting regular hemodialysis at the center95
    Pediatic patients getting regular hemodialysis at the center4
    Pediatric patient months included in in Kt/V greater than or eqaul to 1.218
    Percentage of pediatric patients getting regular hemodialysis at the center

    News Archive

    COVID-19 patients at high risk for developing complications associated with blood clots

    When researchers from the University of Colorado Anschutz Medical Campus, Aurora, used a combination of two specific blood-clotting tests, they found critically ill patients infected with Coronavirus Disease 2019 (COVID-19) who were at high risk for developing renal failure, venous blood clots, and other complications associated with blood clots, such as stroke.

    ScinoPharm to be Clinical Data's sole API supplier of vilazodone hydrochloride during Viibryd's launch

    ScinoPharm, a leading active pharmaceutical ingredient (API) and contract research and manufacturing (CRAM) service provider to the global pharmaceutical and biotechnology industry, will provide commercial manufacturing service of vilazodone hydrochloride active pharmaceutical ingredient (API) for Clinical Data, Inc.'s Viibryd™, a new drug entity recently approved by the United States Food and Drug Administration.

    Bath scientists receive funding to monitor wastewater in cities in the UK and Africa

    Chemists, biologists and mathematicians from the University of Bath have received funding to monitor wastewater in cities in the UK and Africa, to provide an early warning of the potential spread of COVID-19.

    Adding protein sarcospan to muscle cells might help Duchenne muscular dystrophy

    The overlooked and undervalued protein, sarcospan, just got its moment in the spotlight.

    Read more Medical News

    › Verified 5 days ago

  • Peritoneal Dialysis
    Adult patients getting regular peritoneal dialysis at the center115
    Adult patient months included in Kt/V greater than or equal to 1.7952
    Percentage of adult patients getting regular peritoneal dialysis at the center92
    Pediatric patients getting regular peritoneal dialysis at the centre12
    Pediatric patient months included in Kt/V greater than or equal to 1.773
    Percentage of pediatric patients getting regular peritoneal dialysis at the center60

    News Archive

    COVID-19 patients at high risk for developing complications associated with blood clots

    When researchers from the University of Colorado Anschutz Medical Campus, Aurora, used a combination of two specific blood-clotting tests, they found critically ill patients infected with Coronavirus Disease 2019 (COVID-19) who were at high risk for developing renal failure, venous blood clots, and other complications associated with blood clots, such as stroke.

    ScinoPharm to be Clinical Data's sole API supplier of vilazodone hydrochloride during Viibryd's launch

    ScinoPharm, a leading active pharmaceutical ingredient (API) and contract research and manufacturing (CRAM) service provider to the global pharmaceutical and biotechnology industry, will provide commercial manufacturing service of vilazodone hydrochloride active pharmaceutical ingredient (API) for Clinical Data, Inc.'s Viibryd™, a new drug entity recently approved by the United States Food and Drug Administration.

    Bath scientists receive funding to monitor wastewater in cities in the UK and Africa

    Chemists, biologists and mathematicians from the University of Bath have received funding to monitor wastewater in cities in the UK and Africa, to provide an early warning of the potential spread of COVID-19.

    Adding protein sarcospan to muscle cells might help Duchenne muscular dystrophy

    The overlooked and undervalued protein, sarcospan, just got its moment in the spotlight.

    Read more Medical News

    › Verified 5 days ago

Mineral and Bone Disorder

An important goal of dialysis is to maintain normal levels of various minerals in the body, such as calcium. This shows the percentage of patients treated at Piedmont Dialysis Center Of Wake Forest University with elevated calcium levels.

Patients with hypercalcemia313
Hypercalcemia patient months2832
Patients with Serumphosphor325
Patients with Serumphosphor less than 3.5 mg/dL10
Patients with Serumphosphor from 3.5 to 4.5 mg/dL22
Patients with Serumphosphor from 4.6 to 5.5 mg/dL28
Patients with Serumphosphor from 5.6 to 7 mg/dL26
Patients with Serumphosphor greater than 7 mg/dL14

News Archive

COVID-19 patients at high risk for developing complications associated with blood clots

When researchers from the University of Colorado Anschutz Medical Campus, Aurora, used a combination of two specific blood-clotting tests, they found critically ill patients infected with Coronavirus Disease 2019 (COVID-19) who were at high risk for developing renal failure, venous blood clots, and other complications associated with blood clots, such as stroke.

ScinoPharm to be Clinical Data's sole API supplier of vilazodone hydrochloride during Viibryd's launch

ScinoPharm, a leading active pharmaceutical ingredient (API) and contract research and manufacturing (CRAM) service provider to the global pharmaceutical and biotechnology industry, will provide commercial manufacturing service of vilazodone hydrochloride active pharmaceutical ingredient (API) for Clinical Data, Inc.'s Viibryd™, a new drug entity recently approved by the United States Food and Drug Administration.

Bath scientists receive funding to monitor wastewater in cities in the UK and Africa

Chemists, biologists and mathematicians from the University of Bath have received funding to monitor wastewater in cities in the UK and Africa, to provide an early warning of the potential spread of COVID-19.

Adding protein sarcospan to muscle cells might help Duchenne muscular dystrophy

The overlooked and undervalued protein, sarcospan, just got its moment in the spotlight.

Read more Medical News

› Verified 5 days ago

Vascular Access

The arteriovenous (AV) fistulae is considered long term vascular access for hemodialysis because it allows good blood flow, lasts a long time, and is less likely to get infected or cause blood clots than other types of access. Patients who don't have time to get a permanent vascular access before they start hemodialysis treatments may need to use a venous catheter as a temporary access.

Patients included in arterial venous fistula and catheter summaries 186
Patient months included in arterial venous fistula and catheter summaries 1360
Percentage of patients getting regular hemodialysis at the center that used an arteriovenous (AV) fistulae for their treatment65
Percentage of patients receiving treatment through Vascular Catheter for 90 days/longer24

News Archive

COVID-19 patients at high risk for developing complications associated with blood clots

When researchers from the University of Colorado Anschutz Medical Campus, Aurora, used a combination of two specific blood-clotting tests, they found critically ill patients infected with Coronavirus Disease 2019 (COVID-19) who were at high risk for developing renal failure, venous blood clots, and other complications associated with blood clots, such as stroke.

ScinoPharm to be Clinical Data's sole API supplier of vilazodone hydrochloride during Viibryd's launch

ScinoPharm, a leading active pharmaceutical ingredient (API) and contract research and manufacturing (CRAM) service provider to the global pharmaceutical and biotechnology industry, will provide commercial manufacturing service of vilazodone hydrochloride active pharmaceutical ingredient (API) for Clinical Data, Inc.'s Viibryd™, a new drug entity recently approved by the United States Food and Drug Administration.

Bath scientists receive funding to monitor wastewater in cities in the UK and Africa

Chemists, biologists and mathematicians from the University of Bath have received funding to monitor wastewater in cities in the UK and Africa, to provide an early warning of the potential spread of COVID-19.

Adding protein sarcospan to muscle cells might help Duchenne muscular dystrophy

The overlooked and undervalued protein, sarcospan, just got its moment in the spotlight.

Read more Medical News

› Verified 5 days ago

Hospitalization Rate

The rate of hospitalization show you whether patients who were being treated regularly at a certain dialysis center were admitted to the hospital more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other centers.

Standard Hospitalization Summary Ratio(SHR) YearJanuary, 2016 - December, 2016
Patients in facility's Hospitalization Summary274
Hospitalization Rate in facility206.3 (As Expected)
Hospitalization Rate: Upper Confidence Limit279.9
Hospitalization Rate: Lower Confidence Limit159.2

News Archive

COVID-19 patients at high risk for developing complications associated with blood clots

When researchers from the University of Colorado Anschutz Medical Campus, Aurora, used a combination of two specific blood-clotting tests, they found critically ill patients infected with Coronavirus Disease 2019 (COVID-19) who were at high risk for developing renal failure, venous blood clots, and other complications associated with blood clots, such as stroke.

ScinoPharm to be Clinical Data's sole API supplier of vilazodone hydrochloride during Viibryd's launch

ScinoPharm, a leading active pharmaceutical ingredient (API) and contract research and manufacturing (CRAM) service provider to the global pharmaceutical and biotechnology industry, will provide commercial manufacturing service of vilazodone hydrochloride active pharmaceutical ingredient (API) for Clinical Data, Inc.'s Viibryd™, a new drug entity recently approved by the United States Food and Drug Administration.

Bath scientists receive funding to monitor wastewater in cities in the UK and Africa

Chemists, biologists and mathematicians from the University of Bath have received funding to monitor wastewater in cities in the UK and Africa, to provide an early warning of the potential spread of COVID-19.

Adding protein sarcospan to muscle cells might help Duchenne muscular dystrophy

The overlooked and undervalued protein, sarcospan, just got its moment in the spotlight.

Read more Medical News

› Verified 5 days ago

Readmission Rate

The rate of readmission show you whether patients who were being treated regularly at Piedmont Dialysis Center Of Wake Forest University were readmitted more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other dialysis centers.

Standard Readmission Summary Ratio(SRR) YearJanuary, 2016 - December, 2016
Readmission Rate in facility27 (As Expected)
Readmission Rate: Upper Confidence Limit34
Readmission Rate: Lower Confidence Limit20.7

News Archive

COVID-19 patients at high risk for developing complications associated with blood clots

When researchers from the University of Colorado Anschutz Medical Campus, Aurora, used a combination of two specific blood-clotting tests, they found critically ill patients infected with Coronavirus Disease 2019 (COVID-19) who were at high risk for developing renal failure, venous blood clots, and other complications associated with blood clots, such as stroke.

ScinoPharm to be Clinical Data's sole API supplier of vilazodone hydrochloride during Viibryd's launch

ScinoPharm, a leading active pharmaceutical ingredient (API) and contract research and manufacturing (CRAM) service provider to the global pharmaceutical and biotechnology industry, will provide commercial manufacturing service of vilazodone hydrochloride active pharmaceutical ingredient (API) for Clinical Data, Inc.'s Viibryd™, a new drug entity recently approved by the United States Food and Drug Administration.

Bath scientists receive funding to monitor wastewater in cities in the UK and Africa

Chemists, biologists and mathematicians from the University of Bath have received funding to monitor wastewater in cities in the UK and Africa, to provide an early warning of the potential spread of COVID-19.

Adding protein sarcospan to muscle cells might help Duchenne muscular dystrophy

The overlooked and undervalued protein, sarcospan, just got its moment in the spotlight.

Read more Medical News

› Verified 5 days ago

Infection Rate

Hemodialysis treatment requires direct access to the bloodstream, which can be an opportunity for germs to enter the body and cause infection. This information shows how often patients at Piedmont Dialysis Center Of Wake Forest University get infections in their blood each year compared to the number of infections expected for the center based on the national average.

Standard Infection Summary Ratio(SIR) YearJanuary, 2016 - December, 2016
Infection Rate in facility1.79 (Worse than Expected)
SIR: Upper Confidence Limit2.62
SIR: Lower Confidence Limit1.17

News Archive

COVID-19 patients at high risk for developing complications associated with blood clots

When researchers from the University of Colorado Anschutz Medical Campus, Aurora, used a combination of two specific blood-clotting tests, they found critically ill patients infected with Coronavirus Disease 2019 (COVID-19) who were at high risk for developing renal failure, venous blood clots, and other complications associated with blood clots, such as stroke.

ScinoPharm to be Clinical Data's sole API supplier of vilazodone hydrochloride during Viibryd's launch

ScinoPharm, a leading active pharmaceutical ingredient (API) and contract research and manufacturing (CRAM) service provider to the global pharmaceutical and biotechnology industry, will provide commercial manufacturing service of vilazodone hydrochloride active pharmaceutical ingredient (API) for Clinical Data, Inc.'s Viibryd™, a new drug entity recently approved by the United States Food and Drug Administration.

Bath scientists receive funding to monitor wastewater in cities in the UK and Africa

Chemists, biologists and mathematicians from the University of Bath have received funding to monitor wastewater in cities in the UK and Africa, to provide an early warning of the potential spread of COVID-19.

Adding protein sarcospan to muscle cells might help Duchenne muscular dystrophy

The overlooked and undervalued protein, sarcospan, just got its moment in the spotlight.

Read more Medical News

› Verified 5 days ago

Transfusion Summary

Patients with anemia require blood transfusions if their anemia is not managed well by their dialysis center. This information shows whether Piedmont Dialysis Center Of Wake Forest University's rate of transfusions is better than expected, as expected, or worse than expected, compared to other centers that treat similar patients.

Standard Transfusion Summary Ratio (STrR) Year January, 2016 - December, 2016
Patients in facility's Transfusion Summary 227
Transfusion Rate in facility55.5 (As Expected)
Transfusion Rate: Upper Confidence Limit85
Transfusion Rate: Lower Confidence Limit38.2

News Archive

COVID-19 patients at high risk for developing complications associated with blood clots

When researchers from the University of Colorado Anschutz Medical Campus, Aurora, used a combination of two specific blood-clotting tests, they found critically ill patients infected with Coronavirus Disease 2019 (COVID-19) who were at high risk for developing renal failure, venous blood clots, and other complications associated with blood clots, such as stroke.

ScinoPharm to be Clinical Data's sole API supplier of vilazodone hydrochloride during Viibryd's launch

ScinoPharm, a leading active pharmaceutical ingredient (API) and contract research and manufacturing (CRAM) service provider to the global pharmaceutical and biotechnology industry, will provide commercial manufacturing service of vilazodone hydrochloride active pharmaceutical ingredient (API) for Clinical Data, Inc.'s Viibryd™, a new drug entity recently approved by the United States Food and Drug Administration.

Bath scientists receive funding to monitor wastewater in cities in the UK and Africa

Chemists, biologists and mathematicians from the University of Bath have received funding to monitor wastewater in cities in the UK and Africa, to provide an early warning of the potential spread of COVID-19.

Adding protein sarcospan to muscle cells might help Duchenne muscular dystrophy

The overlooked and undervalued protein, sarcospan, just got its moment in the spotlight.

Read more Medical News

› Verified 5 days ago

Survival Summary

The rate of mortality show you whether patients who were being treated regularly at Piedmont Dialysis Center Of Wake Forest University lived longer than expected (better than expected), don’t live as long as expected (worse than expected), or lived as long as expected (as expected), compared to similar patients treated at other facilities.

Standard Survival Summary Ratio(SIR) YearJanuary, 2013 - December, 2016
Patients in facility's Survival Summary1403
Mortality Rate in facility17.5 (As Expected)
Mortality Rate: Upper Confidence Limit20.5
Mortality Rate: Lower Confidence Limit14.8

News Archive

COVID-19 patients at high risk for developing complications associated with blood clots

When researchers from the University of Colorado Anschutz Medical Campus, Aurora, used a combination of two specific blood-clotting tests, they found critically ill patients infected with Coronavirus Disease 2019 (COVID-19) who were at high risk for developing renal failure, venous blood clots, and other complications associated with blood clots, such as stroke.

ScinoPharm to be Clinical Data's sole API supplier of vilazodone hydrochloride during Viibryd's launch

ScinoPharm, a leading active pharmaceutical ingredient (API) and contract research and manufacturing (CRAM) service provider to the global pharmaceutical and biotechnology industry, will provide commercial manufacturing service of vilazodone hydrochloride active pharmaceutical ingredient (API) for Clinical Data, Inc.'s Viibryd™, a new drug entity recently approved by the United States Food and Drug Administration.

Bath scientists receive funding to monitor wastewater in cities in the UK and Africa

Chemists, biologists and mathematicians from the University of Bath have received funding to monitor wastewater in cities in the UK and Africa, to provide an early warning of the potential spread of COVID-19.

Adding protein sarcospan to muscle cells might help Duchenne muscular dystrophy

The overlooked and undervalued protein, sarcospan, just got its moment in the spotlight.

Read more Medical News

› Verified 5 days ago


Dialysis Facility in Winston Salem, NC

WFU Baptist Medical Center Dialysis Unit
Location: 8 N Hemodialysis, Winston Salem, North Carolina, 27157
Phone: (336) 716-3170
Piedmont Dialysis Center Of Wake Forest University
Location: 655 Cotton Street, Winston Salem, North Carolina, 27101
Phone: (336) 721-1360
Salem Kidney Center Of Wake Forest University
Location: 2705 Boulder Park Court, Winston Salem, North Carolina, 27101
Phone: (336) 761-8808
Northside Dialysis Center Of Wake Forest Univerisity
Location: 500 West Hanes Mill Road, Winston Salem, North Carolina, 27105
Phone: (336) 744-0577
Miller Street Dialysis Center Of Wake Forest University
Location: 120 Miller St, Winston Salem, North Carolina, 27103
Phone: (336) 724-0468

News Archive

COVID-19 patients at high risk for developing complications associated with blood clots

When researchers from the University of Colorado Anschutz Medical Campus, Aurora, used a combination of two specific blood-clotting tests, they found critically ill patients infected with Coronavirus Disease 2019 (COVID-19) who were at high risk for developing renal failure, venous blood clots, and other complications associated with blood clots, such as stroke.

ScinoPharm to be Clinical Data's sole API supplier of vilazodone hydrochloride during Viibryd's launch

ScinoPharm, a leading active pharmaceutical ingredient (API) and contract research and manufacturing (CRAM) service provider to the global pharmaceutical and biotechnology industry, will provide commercial manufacturing service of vilazodone hydrochloride active pharmaceutical ingredient (API) for Clinical Data, Inc.'s Viibryd™, a new drug entity recently approved by the United States Food and Drug Administration.

Bath scientists receive funding to monitor wastewater in cities in the UK and Africa

Chemists, biologists and mathematicians from the University of Bath have received funding to monitor wastewater in cities in the UK and Africa, to provide an early warning of the potential spread of COVID-19.

Adding protein sarcospan to muscle cells might help Duchenne muscular dystrophy

The overlooked and undervalued protein, sarcospan, just got its moment in the spotlight.

Read more Medical News

› Verified 5 days ago


Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.